Overexpression of SPP1 is a prognostic indicator of immune infiltration in lung adenocarcinoma.

Binbin Li, Xue Li, Qingfeng Yang, Yiyang Jiang, Qianwen Zhang, Jingtao Zhang, Wenqiang Cui, Fei Xu

Aging 2024 Feb 07

filter terms:

The extracellular phosphoprotein, secreted phosphoprotein 1 (SPP1), plays a crucial role in various tumors and regulating the immune system. This study aimed to evaluate its prognostic value and relationship to immune infiltration in lung adenocarcinoma (LUAD). In the TCGA and GEO datasets, the information on clinic and transcriptome analysis of SPP1 in non-small-cell lung cancer (NSCLC) was examined accordingly. The association of SPP1 expression with overall survival and clinicopathologic characteristics was investigated by univariate and multivariate analysis. CancerSEA database was utilized to investigate the role of SPP1 at the cellular level by single-cell analysis. Additionally, the CIBERSORT algorithm was utilized to assess the correlation among the immune cells that infiltrated. NSCLC tissues exhibited a notable rise in SPP1 expression compared with that of normal tissues. Furthermore, the overexpression of SPP1 was substantially associated with clinicopathological features and unfavorable survival outcomes in individuals with LUAD, whereas no such correlation was observed in lung squamous cell carcinoma. Immune cells that infiltrate tumors and their corresponding genes were associated with SPP1 expression levels in LUAD. SPP1 is a reliable indicator for assessing LUAD immune infiltration status and prognosis. With this approach, SPP1 can help earlier LUAD diagnosis and act as a possible immunotherapy target.

Citation

Binbin Li, Xue Li, Qingfeng Yang, Yiyang Jiang, Qianwen Zhang, Jingtao Zhang, Wenqiang Cui, Fei Xu. Overexpression of SPP1 is a prognostic indicator of immune infiltration in lung adenocarcinoma. Aging. 2024 Feb 07;16(3):2953-2977